|
1
|
- Nga Tran, Dr.P.H., Exponent
- Brian J. Hasselbalch, FDA
- July 2004
|
|
2
|
- Regulatory programs:
- Risk management
|
|
3
|
|
|
4
|
- A regulatory decision tool
- Foundation for the EPA’s Resource Conservation and Recovery Act
Persistent, Bioaccumulative, and Toxic (PBT) List of chemicals.
- Framework of expert judgment
- Identify chemicals or emissions of potential concern
- Using key physical-chemical properties and associated cutoff criteria.
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
- Comparative risk pre-deployment
- Rank locations based on potential chemical risks
- Risk score is a function of volume and inherent chemical toxicity
- Comparative risk during deployment
- Ranking and comparing disparate risks
- Quick/simple tools
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
|
|
13
|
- Ranking to target products for which additional toxicity testing of High
Production Volume chemical is needed.
- Laundry detergent, consumer care products, etc..
- Many products, limited resources
- Ranking based on exposure to consumer products
- “High end” product use frequency (e.g., number of times use per day) as
surrogate for exposure
|
|
14
|
|
|
15
|
|
|
16
|
- SIEFE: Stepwise and Interactive Evaluation of Food Safety by an Expert
System.
- A decision support system for microbiological risk assessment for food
products and their production processes
- Risks are first assessed broadly, using order of magnitude estimates,
i.e. level 1 risk assessment.
- Characteristic numbers are used to quantitatively characterize microbial
behavior during the production process to highlight the major
risk-determining phenomena
|
|
17
|
|
|
18
|
- Tool to compare food-borne risks for ranking and prioritizing risks from
diverse sources.
- 11 questions relating to 3 main factors:
- severity of hazard
- likelihood of disease causing dose of hazard being present in a meal
- probability of exposure to the hazard
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
- "Inspector Optimization System" (IOS)
- Basis of assigning the processing inspector workforce to provide for
greater flexibility in targeting inspection resources to areas of
greater public health risk and concern
- Report to Congress on Risk-Based Inspection to the United States House
and Senate Appropriations Committees, March 2, 2001
- Each plant receives a Food Safety Hazard Coefficient (HC)
- Inherent hazards
- Expert Elicitation to rank inherent hazards
|
|
23
|
|
|
24
|
|
|
25
|
|
|
26
|
|
|
27
|
- Began one year ago
- Internal experts from CDER, CVM, CBER, and ORA (Risk Mgmt & Workplan
WG)
- Generated a list of risk factors that are descriptors of site risks for
consideration in development of site selection model
- Qualitatively valued: High, Medium, Low
|
|
28
|
|
|
29
|
- High level risk management begins with organization
- Categorized list of risk factors into 3 components
|
|
30
|
|
|
31
|
|
|
32
|
- Selected factors for product, process and facility components
- Assigned weights
- Empirically derived
- Expert judgment
- Developed logical algorithm to combine factors to calculate a site score
– The Model
|
|
33
|
- Drilling Down and Populating the Product, Facility, and Process
Components
|
|
34
|
|
|
35
|
- Data source: FACTS (Field Accomplishments and Compliance Tracking
System)
- Site information/identifier
- Product codes
- CDER Recall Database
- Product codes
- Rx/OTC and Classification of Hazard
- Years:
- Recall: 1997-2004
- Product: 2000-2004
|
|
36
|
|
|
37
|
- Need to link recall data to sites
- Indirect linkage -- correlate product codes in recall data with product
codes in site database
- Recall weights assigned to Recall-FACTs harmonized product codes
|
|
38
|
|
|
39
|
|
|
40
|
- Data source: FACTS (Field Accomplishments and Compliance Tracking
System)
- Years: 2000-2004
- All sites, foreign and domestic
|
|
41
|
|
|
42
|
- No data, but do have staff with experience and knowledge
- \ expert elicitation survey
- Elicitation survey drafting began Nov. 2003
- Inter-Center/ORA workgroup effort
- ORA; CVM; CBER; CDER; CDER; OC
|
|
43
|
- What are the relevant process-related risk factors? (i.e., sources of
variability and poor quality)
- What, if any, unit operations are more liable to a loss of control or
at risk to contamination?
- What products? Answers are product dependent
- Large number of products
- Identify “mutually exclusive” category of products -- tradeoffs in
number of product categories and responder burden
|
|
44
|
|
|
45
|
- Product types
- Several CDER/agency coding schemes; too much
- Types selected are representative of most product types in the market
- Codes grouped into product types with similar unit ops
- Distinguish high/low actives
- Unit operations
- WG member knowledge +
- Remington: Science and Practice of Pharmacy, 20th edition
- Modern Pharmaceutics, 3rd edition
- Pharmaceutical Process Validation, 3rd edition
- ISPE Baseline Pharmaceutical Engineering Guide, vol. 2, Oral Solid
Dosage Forms (1st edition, 1998)
|
|
46
|
|
|
47
|
|
|
48
|
- A) Process control
- To what degree does this unit of operation contribute to variability in
quality of the final product?
- 2) How difficult is it to maintain
this unit of operation in a state of control?
- 3) If a problem does occur, how
reliable are the current detection methods?
- B) Contamination
- 4) Is this unit of operation more
or less vulnerable to contamination from previous product?
- 5) Is this unit of operation more
or less vulnerable to contamination from the environment?
|
|
49
|
|
|
50
|
|
|
51
|
- Delivery By e-mail
- 50 FDA experts participated
- reviewers from CDER
- senior CDER compliance staff
- senior ORA field staff
- 90% response rate
- Results being analyzed
|
|
52
|
- Exploratory Data Analysis (EDA)
- Product rank consistent with unit of operation drill down data –
correlation
- Developing process weights based on unit of operation drill down survey
data
- K-mean cluster analysis
- Average rank per product category per question
- a) Process controls: questions
1, 2 and 3
- b) Contamination potential: questions 4 and 5
- Coefficient of Variance (CV) Weighted average rank per product category
per question
- Principal component and fuzzy arithmetic for expert categorical data
analysis
|
|
53
|
|
|
54
|
- A site will tend to be less frequently selected for inspection if it:
- has been inspected recently and/or relatively few previous violations
of GMPs and/or a smaller volume of product (facility weight);
- makes non-sterile, OTC drugs, and/or other product types that are not
associated with a high frequency of serious recalls (product weight);
- makes products estimated to be relatively straightforward to
manufacture and not vulnerable to contamination (process weight)
|
|
55
|
|
|
56
|
- Can you identify alternative approaches that would systematically
prioritize manufacturing sites for GMP inspections?
- In what areas would additional data provide the most value added in
prioritizing manufacturing sites for GMP inspections?
- Are there other metrics that should be incorporated, e.g., measuring
process control?
|